发明名称 IK FACTOR AND PHARMACEUTICAL USE OF NUCLEIC ACID ENCODING IK FACTOR
摘要 The present invention relates to a pharmaceutical composition for treating and/or preventing arthritis, which comprising, as an active ingredient, a gene delivery vehicle into which an IK factor or a fragment thereof, or a nucleic acid encoding thereof is inserted. IK factor or the fragment thereof, and the nucleic acid encoding thereof, which are the active ingredient of the pharmaceutical composition according to the present invention, are derived from an organism and therefore, show no side effects in administered into a subject for a long time. Accordingly, they ensures safety and are expected to effectively treat arthritis by being involved in the upstream mechanism for suppressing arthritis.
申请公布号 US2016058836(A1) 申请公布日期 2016.03.03
申请号 US201414784614 申请日期 2014.04.16
申请人 CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION ;CELLINBIO CO., LTD 发明人 NAM Jae-Hwan;PARK Hye-Lim;LEE Sang-Myeong;LEE Dong-Hee
分类号 A61K38/19 主分类号 A61K38/19
代理机构 代理人
主权项 1. A method for treating or preventing arthritis, the method comprising administering a pharmaceutically effective amount of IK factor or fragments of IK factor to a subject.
地址 Seoul KR